Active Supportive Care and Symptom Management Grants

PI Name Organization - Company Title FOAsort descending
Yennu, Sriram University Of Tx Md Anderson Can Ctr A Combination Therapy to Treat Cancer-Related Fatigue PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Hui, David University Of Tx Md Anderson Can Ctr Efficacy and Safety of Rapid-Onset Opioids for Exertional Dyspnea in Cancer Patients PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Shelby, Rebecca A Duke University Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Perkins, Susan M Indiana Univ-Purdue Univ At Indianapolis Evaluation of the Communication Plan Early through End-of-Life (COMPLETE) Intervention PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Mao, Jun J Sloan-Kettering Inst Can Research Effect and Mechanism of Acupuncture for Cancer-related Cognitive Impairment (ENHANCE) PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Smith, Ellen Mary Lavoie University Of Alabama At Birmingham Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Washington, Karla Washington University Problem-Solving Therapy for Cancer Caregivers: A Randomized Clinical Trial in Outpatient Palliative Care PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Hui, David University Of Tx Md Anderson Can Ctr Strategies for Persistent Agitated Delirium in Palliative Care PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Bylund, Carma L. University Of Florida Dignity Therapy for Older Cancer Patients: Identifying Mechanisms and Moderators PAR-18-869: Modular R01s in Cancer Control and Population Sciences
Geisler, Stefanie Washington University Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies
Hanks, Brent Allen Duke University Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies
Salvemini, Daniela Saint Louis University Fingolimod and Ozanimod for the treatment and prevention of chemobrain PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies
Geisler, Stefanie Washington University Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies
Strati, Paolo University Of Tx Md Anderson Can Ctr Targeting Myeloid Cells to Mitigate Immune Effector Cell-Associated Neurotoxicity Syndrome in Large B-cell Lymphoma PAR-19-356: NCI Clinical and Translational Exploratory/Developmental Studies
Robien, Kimberly Z George Washington University Body composition and chemotherapy toxicity among women being treated for breast cancer PAR-19-356: NCI Clinical and Translational Exploratory/Developmental Studies

Pages